Sexual Health & Medical Wellness Scripps Research Scientists Develop Breakthrough Vaccine Strategy to Neutralize Entire Class of Fentanyl Variants September 29, 2026 Susilo Ahmad The United States is currently navigating the most lethal phase of its long-standing opioid epidemic, driven largely by the proliferation of illicitly manufactured synthetic opioids. Fentanyl, a potent analgesic originally…
Sexual Health & Medical Wellness A Novel Vaccine Strategy Offers Broad Protection Against Fentanyl and Its Illicit Variants, Marking a Potential Turning Point in the Opioid Crisis. July 12, 2026 Susilo Ahmad The relentless march of fentanyl and its synthetic opioid analogues has cemented their status as the deadliest drug class in the United States, claiming more lives annually than the combined…
Sexual Health & Medical Wellness A Novel Vaccine Strategy Offers Broad Protection Against Fentanyl and Its Illicit Variants, Marking a Potential Turning Point in the Opioid Crisis. July 5, 2026 Susilo Ahmad Fentanyl has solidified its position as one of the most devastating illicit drugs in the United States, driving an unprecedented surge in overdose fatalities. Each year, fentanyl and its rapidly…
Sexual Health & Medical Wellness Experimental Vaccine Developed by Scripps Research Offers Broad Protection Against Fentanyl and Its Illicit Variants. June 28, 2026 Susilo Ahmad Fentanyl has emerged as an unprecedented public health crisis in the United States, cementing its status as one of the deadliest drugs of the modern era. Each year, fentanyl and…
Sexual Health & Medical Wellness Groundbreaking Vaccine Developed by Scripps Research Offers Broad Protection Against Fentanyl and Its Evolving Variants June 21, 2026 Susilo Ahmad Fentanyl, a synthetic opioid 50 to 100 times more potent than morphine, has rapidly ascended to become the deadliest drug in the United States, driving an unprecedented public health crisis.…
Psychology & Intimacy Single-nucleus chromatin accessibility profiling identifies cell types and functional variants contributing to major depression June 2, 2026 Rebecca Shoemaker A groundbreaking discovery by researchers at McGill University and the Douglas Institute is poised to revolutionize our understanding of depression, identifying for the first time specific brain cell types that…
Psychology & Intimacy Single-nucleus chromatin accessibility profiling identifies cell types and functional variants contributing to major depression May 22, 2026 Rebecca Shoemaker A groundbreaking study by researchers at McGill University and the Douglas Institute has unveiled a critical insight into the biological underpinnings of depression, identifying for the first time specific types…
Psychology & Intimacy Single-nucleus chromatin accessibility profiling identifies cell types and functional variants contributing to major depression May 15, 2026 Rebecca Shoemaker Researchers at McGill University and the Douglas Institute have unveiled groundbreaking insights into the biological underpinnings of depression, identifying two distinct types of brain cells that exhibit altered function in…
Psychology & Intimacy Single-nucleus chromatin accessibility profiling identifies cell types and functional variants contributing to major depression May 8, 2026 Rebecca Shoemaker Researchers at McGill University and the Douglas Institute have unveiled groundbreaking insights into the biological underpinnings of depression, identifying two distinct types of brain cells that exhibit altered functionality in…
Psychology & Intimacy Single-nucleus chromatin accessibility profiling identifies cell types and functional variants contributing to major depression April 30, 2026 Rebecca Shoemaker A groundbreaking study by researchers at McGill University and the Douglas Institute has unveiled critical new insights into the biological underpinnings of depression, identifying two distinct types of brain cells…
